Grifols (GIFLF) Payout Ratio (2013 - 2025)
Grifols' (GIFLF) quarterly Payout Ratio came in at 256.0 in Q4 2025, down 5352.8% on a YoY basis from 4.87 in Q4 2024, and down 5352.8% quarter-over-quarter from 4.69 in Q4 2024.
Analysis
Grifols (GIFLF) Payout Ratio (2013 - 2025) Analysis & Trends
Grifols (GIFLF) has reported Payout Ratio for 10 consecutive years, with 256.0 the latest figure, recorded in Q4 2025.
- For the quarter ending Q4 2025, Payout Ratio fell 5352.8% year-over-year to 256.0; the trailing twelve-month figure through Dec 2025 stood at 0.98 (down 163.73% YoY), and the FY2025 full-year result was 0.32, down 4899.0% from the prior year.
- Payout Ratio declined to 256.0 in Q4 2025 per GIFLF's latest filing, from 4.69 in the prior quarter.
- Across five years, Payout Ratio topped out at 0.04 in Q4 2022 and bottomed at 256.0 in Q4 2025.
- Historically, Payout Ratio has averaged 86.88 across 3 years, with a median of 4.69 in 2024.
- The widest YoY moves for Payout Ratio: up 5352.8% in 2025, down 5352.8% in 2025.
- Over 3 years, Payout Ratio stood at 0.04 in 2022, then slumped by 11594.91% to 4.69 in 2024, then slumped by 5352.8% to 256.0 in 2025.
- According to Business Quant data, Payout Ratio over the past three periods registered 256.0, 4.69, and 0.04 for Q4 2025, Q4 2024, and Q4 2022 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 203.97 Bn | 189.99 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 178.74 Bn | 175.56 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.73 Bn | 122.88 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 80.42 Bn | 72.42 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.40 Bn | 55.21 Bn | 1.37 Bn |
| 6 | Moderna | 57.65 Bn | 52.52 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.37 Bn | 30.07 Bn | 992.69 Mn |
| 8 | Biogen | 32.15 Bn | 30.86 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.58 Bn | 29.58 Bn | 1.16 Mn |
| 10 | Grifols | 7.54 Bn | 9.09 Bn | 3.33 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -256.00 |
| Dec 31, 2024 | -4.69 |
| Dec 31, 2022 | 0.04 |
| Dec 31, 2019 | -0.14 |
| Dec 31, 2018 | 0.19 |
| Dec 31, 2017 | 0.13 |
| Dec 31, 2016 | -0.88 |
| Sep 30, 2016 | -1.32 |
| Dec 31, 2015 | -2.48 |
| Dec 31, 2014 | 0.65 |
| Dec 31, 2013 | 0.00 |
| Sep 30, 2013 | 0.00 |